Skip to main content

November 2015

 

 

academics

 

Clinical research courses

The INSPIRE consortium, led by Videregen Ltd, has received approval from the MHRA to start a UK clinical trial with its tissue engineered replacement trachea. The trial, which is expected to start in the first half of 2016, will focus on severe structural airway disease (SSAD), a potentially life-threatening condition believed to affect 19,000 people in Europe and the US.  Along with Videregen as commercial partner, the consortium includes the Cell Therapy Catapult, University College London (UCL), NHS Blood and Transplant in Speke and the Royal Free London NHS Foundation Trust.

Opportunity for Pharmacist (645 Posts) in National Health Mission MP

The National Health Mission (NHM) was launched by the Hon’ble Prime Minister on 12th April 2005, to provide accessible, affordable and quality health care to the rural population, especially the vulnerable groups. The Union Cabinet vide its decision dated 1st May 2013, has approved the launch of National Urban Health Mission (NUHM) as a Sub-mission of an over-arching National Health Mission (NHM), with National Rural Health Mission (NRHM) being the other Sub-mission of National Health Mission.

Work for B.Pharm, M.Pharm as Chief Manager in Abbott

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 69,000 people.

Work as Medical Science Liasion - Instrumentation in Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Eating a Mediterranean diet or other healthy dietary pattern, comprising of fruit, vegetables, legumes and nuts, is associated with preventing the onset of depression, according to s new large study. The study of 15,093 people suggests depression could be linked with nutrient deficits.

Drug major Sun Pharma Industries  said it has completed acquisition of US-based eye care firm InSite Vision. The acquisition was completed by means of a short-form merger under the Delaware law, Sun Pharma said in a statement. Post-merger, InSite Vision has become an indirect wholly-owned subsidiary of Sun Pharma.

The company in September had announced its plan to acquire InSite Vision for around USD 48 million plus related debt and other transaction costs to strengthen its branded ophthalmic portfolio in the US. The company said "each issued and outstanding share of InSite common stock was converted into the right to receive USD 0.35 as a result of the merger".

InSite will no longer have reporting obligations under the Securities Exchange Act of 1934 as amended.

"Holders of shares of InSite common stock that did not tender their shares into the tender offer will receive by mail written instructions for surrendering their share certificates or transferring their book-entry shares, including a letter of transmittal, and information regarding the exercise of appraisal rights under the Delaware law," the statement added.



<< Pharma News

Subscribe to PharmaTutor News Alerts by Email >>